Commentary on ‘How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia?’ by Grosse and Van Vliet, Hormone Research, 2007;67:284–291

By  

Hormone Research in Paediatrics, Vol. 68, Iss. 4, 2007-03 ,pp. : 195-195

Karger

Access to resources Recommend Favorite

How Can Molecular Biology Contribute to the Management of Congenital Adrenal Hyperplasia?

By  

Hormone Research in Paediatrics, Vol. 53, Iss. 1, 2004-11 ,pp. : 34-37

Karger

Access to resources Recommend Favorite

Evaluation of Neonatal Screening for Congenital Adrenal Hyperplasia

By  

Hormone Research in Paediatrics, Vol. 55, Iss. 4, 2001-10 ,pp. : 206-211

Karger

Access to resources Recommend Favorite

Growth Patterns in the First Three Years of Life in Children with Classical Congenital Adrenal Hyperplasia Diagnosed by Newborn Screening and Treated with Low Doses of Hydrocortisone

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 1, 2010-08 ,pp. : 32-37

Karger

Access to resources Recommend Favorite

Neonatal Screening Program for Congenital Adrenal Hyperplasia: Adjustments to the Recall Protocol

By  

Hormone Research in Paediatrics, Vol. 55, Iss. 6, 2002-01 ,pp. : 271-277

Karger

Access to resources Recommend Favorite